Reported Earnings • Apr 14
Full year 2025 earnings released: CN¥0.12 loss per share (vs CN¥0.074 loss in FY 2024) Full year 2025 results: CN¥0.12 loss per share (further deteriorated from CN¥0.074 loss in FY 2024). Revenue: CN¥109.7m (up 117% from FY 2024). Net loss: CN¥239.6m (loss widened 62% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 34 percentage points per year, which is a significant difference in performance. Announcement • Apr 09
Jiutian Chemical Group Limited, Annual General Meeting, Apr 24, 2026 Jiutian Chemical Group Limited, Annual General Meeting, Apr 24, 2026, at 10:00 Singapore Standard Time. Location: voco orchard singapore, panorama 2, level 24, 581 orchard rd, singapore 238883, Singapore New Risk • Mar 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 53% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (S$41.8m market cap, or US$32.8m). Reported Earnings • Feb 27
Full year 2025 earnings released: CN¥0.084 loss per share (vs CN¥0.074 loss in FY 2024) Full year 2025 results: CN¥0.084 loss per share (further deteriorated from CN¥0.074 loss in FY 2024). Revenue: CN¥107.5m (up 113% from FY 2024). Net loss: CN¥167.0m (loss widened 13% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 32 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 13
First half 2025 earnings released First half 2025 results: CN¥0.033 loss per share. Revenue: CN¥83.1m (up 34% from 1H 2024). Net loss: CN¥64.7m (loss narrowed 23% from 1H 2024). Reported Earnings • Apr 12
Full year 2024 earnings released: CN¥0.074 loss per share (vs CN¥0.17 loss in FY 2023) Full year 2024 results: CN¥0.074 loss per share (improved from CN¥0.17 loss in FY 2023). Net loss: CN¥147.9m (loss narrowed 57% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 51 percentage points per year, which is a significant difference in performance. Announcement • Apr 10
Jiutian Chemical Group Limited, Annual General Meeting, Apr 25, 2025 Jiutian Chemical Group Limited, Annual General Meeting, Apr 25, 2025, at 10:00 Singapore Standard Time. Location: voco orchard singapore, panorama 2, level 24, 581 orchard rd, singapore 238883, Singapore New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (S$43.7m market cap, or US$32.5m). Reported Earnings • Feb 21
Full year 2024 earnings released: CN¥0.074 loss per share (vs CN¥0.17 loss in FY 2023) Full year 2024 results: CN¥0.074 loss per share (improved from CN¥0.17 loss in FY 2023). Revenue: CN¥243.8m (down 59% from FY 2023). Net loss: CN¥147.8m (loss narrowed 57% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Announcement • Feb 14
Jiutian Chemical Group Limited Announces Change of Company Secretary The Board of Directors of Jiutian Chemical Group Limited announced the appointment of Ms Chiang Wai Ming as the Company Secretary of the Company in place of Ms. Pan Mi Keay with effect from 14 February 2025. The Board would like to take this opportunity to place its record of appreciation to Ms. Pan Mi Keay for her past services to the Company. Reported Earnings • Nov 16
Third quarter 2024 earnings released Third quarter 2024 results: CN¥0.019 loss per share. Revenue: CN¥5.47m (down 93% from 3Q 2023). Net loss: CN¥36.9m (loss narrowed 46% from 3Q 2023). Reported Earnings • Aug 08
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: CN¥17.3m (down 89% from 2Q 2023). Net loss: CN¥36.5m (loss narrowed 29% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance. Board Change • Jun 01
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Non-Executive Independent Director Gang Wong was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Apr 27
Jiutian Chemical Group Limited Announces Appointments and Changes to the Composition of Board of Directors and Board Committees The Board of Directors (the "Board") of Jiutian Chemical Group Limited announce the following:- Appointment of Non-Executive and Independent Directors: The following persons will be appointed as Non-Executive and Independent Directors with effect from 1 May 2024: Mr. Lim Kian Thong; Mr. Wong Gang; Mr. Wang Hongli; and Mr. Wang Zilong. Changes to the Composition of Board of Directors and Board Committees: Consequent to the aforesaid changes, the composition of the Board and Board Committees of the Company will be as follows: Board of Directors: Mr. Xu Aijun Non-Executive and Non-Independent Chairman; Mr. Lee Chee Seng Executive Director; Mr. Wang Gang Non-Executive and Non-Independent Director; Mr. Song Fudong Non-Executive and Non-Independent Director; Mr. Koh Eng Kheng Victor Non-Executive and Lead Independent Director; Mr. Wong Gang Non-Executive and Independent Director; Mr. Lim Kian Thong Non-Executive and Independent Director; Mr. Wang Zilong Non-Executive and Independent Director; Mr. Wang Hongli Non-Executive and Independent Director. Audit Committee: Mr. Lim Kian Thong Chairman, Mr. Koh Eng Kheng Victor Member, Mr. Wong Gang Member. Nominating Committee: Mr. Koh Eng Kheng Victor Chairman, Mr. Lim Kian Thong Member, Mr. Xu Aijun Member, Remuneration Committee: Mr. Wong Gang Chairman, Mr. Koh Eng Kheng Victor Member, Mr. Lim Kian Thong Member. Reported Earnings • Apr 26
First quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.056 loss in 1Q 2023) First quarter 2024 results: CN¥0.024 loss per share (improved from CN¥0.056 loss in 1Q 2023). Revenue: CN¥44.9m (down 81% from 1Q 2023). Net loss: CN¥48.1m (loss narrowed 57% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 14
Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.25 profit in FY 2022) Full year 2023 results: CN¥0.17 loss per share (down from CN¥0.25 profit in FY 2022). Revenue: CN¥598.6m (down 75% from FY 2022). Net loss: CN¥344.6m (down 170% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 43% per year whereas the company’s share price has fallen by 39% per year. Announcement • Apr 09
Jiutian Chemical Group Limited, Annual General Meeting, Apr 25, 2024 Jiutian Chemical Group Limited, Annual General Meeting, Apr 25, 2024, at 10:30 Singapore Standard Time. Location: Royal Plaza on Scotts, Balmoral Hall, Level 5, 25 Scotts Road Singapore Singapore Agenda: To receive and adopt the Directors Statement and the Audited Financial; to consider the proposed renewal of the Share Buyback Mandate; to approve the payment of Directors fee; to approve the payment of special one-time additional Directors fees; to consider re-election of Directors; to re-appoint Messrs Baker Tilly TFW LLP as Auditors of the Company and to authorize the Directors to fix their remuneration; and to transact any other ordinary business which may properly be transacted at an Annual General Meeting. Reported Earnings • Mar 02
Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.25 profit in FY 2022) Full year 2023 results: CN¥0.17 loss per share (down from CN¥0.25 profit in FY 2022). Revenue: CN¥598.6m (down 75% from FY 2022). Net loss: CN¥344.6m (down 170% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings. Announcement • Feb 16
Jiutian Chemical Group Limited to Report Fiscal Year 2023 Results on Feb 29, 2024 Jiutian Chemical Group Limited announced that they will report fiscal year 2023 results on Feb 29, 2024 New Risk • Jan 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Singaporean stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Market cap is less than US$100m (S$51.7m market cap, or US$38.6m). Reported Earnings • Nov 08
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: CN¥80.2m (down 85% from 3Q 2022). Net loss: CN¥68.6m (down 173% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings. New Risk • Oct 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (S$55.7m market cap, or US$40.7m). New Risk • Aug 04
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 23% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Market cap is less than US$100m (S$91.5m market cap, or US$68.2m). Reported Earnings • Aug 04
Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.093 profit in 2Q 2022) Second quarter 2023 results: CN¥0.026 loss per share (down from CN¥0.093 profit in 2Q 2022). Revenue: CN¥161.6m (down 75% from 2Q 2022). Net loss: CN¥51.2m (down 128% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 36% per year whereas the company’s share price has increased by 37% per year. Buying Opportunity • Jul 25
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 30%. The fair value is estimated to be S$0.062, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% over the last 3 years. Meanwhile, the company has become profitable. Announcement • May 13
Jiutian Chemical Group Limited Declares Interim Tax Exempt (One-Tier) Dividend for the Financial Year 2023, Payable on 16 June 2023 Jiutian Chemical Group Limited announced that the Share Transfer Books and Register of Members of Jiutian Chemical Group Limited will be closed at 5.00 p.m. on 8 June 2023 for the purpose of determining shareholders' entitlements to the proposed tax exempt (one-tier) interim dividend of SGD 0.009 per ordinary share. Shareholders (being depositors) whose securities accounts with The Central Depository (Pte) Limited are credited with shares of the Company at 5.00 p.m. on the 8 June 2023 will be entitled to the FY2023 Interim Dividend. The FY2023 Interim Dividend will be paid on 16 June 2023. Reported Earnings • Apr 15
Full year 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.16 in FY 2021) Full year 2022 results: EPS: CN¥0.25 (up from CN¥0.16 in FY 2021). Revenue: CN¥2.43b (up 12% from FY 2021). Net income: CN¥490.5m (up 51% from FY 2021). Profit margin: 20% (up from 15% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 83% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 01
Full year 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.16 in FY 2021) Full year 2022 results: EPS: CN¥0.25 (up from CN¥0.16 in FY 2021). Revenue: CN¥2.43b (up 12% from FY 2021). Net income: CN¥490.5m (up 51% from FY 2021). Profit margin: 20% (up from 15% in FY 2021). The increase in margin was driven by higher revenue. Revenue is expected to decline by 22% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Asia are expected to grow by 11%. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 80% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 4 highly experienced directors. Non-Executive & Non-Independent Director Fudong Song was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 10
Third quarter 2022 earnings released Third quarter 2022 results: EPS: CN¥0.047. Revenue: CN¥520.1m (up 25% from 3Q 2021). Net income: CN¥93.5m (up 64% from 3Q 2021). Profit margin: 18% (up from 14% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is expected to decline by 12% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Asia are expected to grow by 11%. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 68% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 13
Second quarter 2022 earnings released: EPS: CN¥0.093 (vs CN¥0.035 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.093 (up from CN¥0.035 in 2Q 2021). Revenue: CN¥657.6m (up 47% from 2Q 2021). Net income: CN¥184.5m (up 163% from 2Q 2021). Profit margin: 28% (up from 16% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 18% compared to a 24% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 89% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Aug 12
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from CN¥0.24 to CN¥0.27. Revenue forecast steady at CN¥2.41b. Net income forecast to grow 15% next year vs 22% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.19 to S$0.20. Share price was steady at S$0.094 over the past week. Announcement • Aug 02
Jiutian Chemical Group Limited Provides Profit Guidance for Half Year Ended 30 June 2022 Jiutian Chemical Group Limited provided profit guidance for half year ended 30 June 2022. For the period the company announced that following a preliminary review of the unaudited results for the half year ended 30 June 2022, the Group is expected to report a significant increase in consolidated net profit, compared to the corresponding prior year period. Announcement • Jun 24
Jiutian Chemical Group Limited Approves the Appointment of Song Fudong as the Non-Executive and Non-Independent Director Jiutian Chemical Group Limited approved the appointment of Song Fudong as the Non-Executive and Non-Independent Director of the Company. Working Experience: From April 2022 till present he is Chief Financial Officer of Anyang Chemical Industry Group Co. Ltd. November 2020 - March 2022 he was Assistant General Manager of Anyang Chemical Industry Group Co. Ltd. January 2015 - October 2020: Finance Manager of Anyang Chemical Industry Group Co. Ltd. December 2008 - December 2014 he was Assistant Finance Manager of Anyang Chemical Industry Group Co. Ltd. Song is currently the Chief Financial Officer of Anyang Chemical Industry Group Co. Ltd. ("Anhua"), the controlling shareholder of the Company. He had been working in Anhua's finance department since 1991. Professional Qualifications is Bachelor of Economics from Henan University. Major Estimate Revision • May 11
Consensus revenue estimates increase by 18% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from CN¥1.92b to CN¥2.27b. EPS estimate increased from CN¥0.17 to CN¥0.20 per share. Net income forecast to shrink 13% next year vs 19% growth forecast for Chemicals industry in Singapore . Consensus price target up from S$0.16 to S$0.17. Share price rose 6.4% to S$0.10 over the past week. Reported Earnings • May 05
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: CN¥0.10 (up from CN¥0.045 in 1Q 2021). Revenue: CN¥772.3m (up 76% from 1Q 2021). Net income: CN¥201.1m (up 123% from 1Q 2021). Profit margin: 26% (up from 21% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 23%. Earnings per share (EPS) also surpassed analyst estimates by 1.0%. Over the next year, revenue is expected to shrink by 24% compared to a 22% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 75% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. Non-Executive & Non-Independent Chairman Lianguo Han was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Apr 22
Jiutian Chemical Group Limited Announces Final Tax Exempt Dividend for the Financial Year Ended 31 December 2021, Payable on 27 May 2022 Jiutian Chemical Group Limited announced the final tax exempt (one-tier) dividend of SGD 0.0012 per ordinary share for the financial year ended 31 December 2021, if approved by the shareholders at the forthcoming Annual General Meeting of the Company to be held on 28 April 2022 at 10.30am, would be payable on 27 May 2022 to shareholders. Reported Earnings • Apr 10
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥0.16 (up from CN¥0.094 in FY 2020). Revenue: CN¥2.17b (up 90% from FY 2020). Net income: CN¥324.9m (up 87% from FY 2020). Profit margin: 15% (in line with FY 2020). Revenue exceeded analyst estimates by 23%. Earnings per share (EPS) also surpassed analyst estimates by 1.0%. Over the next year, revenue is expected to shrink by 12% compared to a 29% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 65% per year, which means it is significantly lagging earnings growth. Announcement • Apr 07
Jiutian Chemical Group Limited Announces Re-Designation of Gao Guoan as Non-Executive and Non-Independent Director, Effective 26 April 2022 Jiutian Chemical Group Limited announced re-designation of Gao Guoan, non-executive and independent director to non-executive and non-independent director, effective 26 April 2022. Working Experience: April 2013 to Present: Non-Executive and Independent Director of the Company December 2008 - February 2015: Independent Director of Zhengzhou Coal Mining Machinery Group Co. Ltd. Major Estimate Revision • Apr 06
Consensus revenue estimates increase by 20% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from CN¥1.60b to CN¥1.92b. EPS estimate increased from CN¥0.14 to CN¥0.17 per share. Net income forecast to grow 8.5% next year vs 21% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.14 to S$0.16. Share price rose 5.8% to S$0.091 over the past week. Announcement • Feb 27
Jiutian Chemical Group Limited Proposes Final Tax Exempt Dividend for the Financial Year Ended 31 December 2021 Jiutian Chemical Group Limited proposes final tax exempt dividend of SGD 0.0012 per share for the financial year ended 31 December 2021. The dividend is subject to shareholders' approval at the upcoming annual general meeting of the company to be held in April 2022. Reported Earnings • Feb 27
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥0.16 (up from CN¥0.094 in FY 2020). Revenue: CN¥2.17b (up 90% from FY 2020). Net income: CN¥310.3m (up 79% from FY 2020). Profit margin: 14% (in line with FY 2020). Revenue exceeded analyst estimates by 23%. Earnings per share (EPS) also surpassed analyst estimates by 1.0%. Over the next year, revenue is expected to shrink by 26% compared to a 28% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Dec 30
Executive Director recently bought S$219k worth of stock On the 28th of December, Chee Seng Lee bought around 3m shares on-market at roughly S$0.073 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold S$2.2m more in shares than they bought in the last 12 months. Reported Earnings • Nov 13
Third quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.029 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥416.7m (up 56% from 3Q 2020). Net income: CN¥56.9m (up 9.5% from 3Q 2020). Profit margin: 14% (down from 20% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 54% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Jun 04
Executive Director recently sold S$2.4m worth of stock On the 1st of June, Chee Seng Lee sold around 25m shares on-market at roughly S$0.098 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of S$2.3m more than they bought in the last 12 months. Announcement • May 15
Jiutian Chemical Group Limited Declares Interim Dividend, Payable on June 18, 2021 The Board of Directors of Jiutian Chemical Group Limited declared an interim dividend of SGD 0.0035 per ordinary share, which will be paid on 18 June 2021 to all shareholders on record as 3 June, 2021. Major Estimate Revision • May 05
Consensus EPS estimates increase to CN¥0.14 The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥1.34b to CN¥1.46b. EPS estimate increased from CN¥0.12 to CN¥0.14 per share. Net income forecast to grow 7.8% next year vs 36% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.14 to S$0.14. Share price fell 4.0% to S$0.096 over the past week. Reported Earnings • Apr 18
Full year 2020 earnings released: EPS CN¥0.094 (vs CN¥0.14 loss in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.15b (up 8.7% from FY 2019). Net income: CN¥173.7m (up CN¥422.1m from FY 2019). Profit margin: 15% (up from net loss in FY 2019). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. Reported Earnings • Feb 24
Full year 2020 earnings released The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.15b (up 8.7% from FY 2019). Net income: CN¥173.7m (up CN¥422.1m from FY 2019). Profit margin: 15% (up from net loss in FY 2019). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 139 percentage points per year, which is a significant difference in performance. Analyst Estimate Surprise Post Earnings • Feb 24
Revenue and earnings miss expectations Revenue missed analyst estimates by 0.3%. Earnings per share (EPS) also missed analyst estimates by 13%. Over the next year, revenue is forecast to grow 25%, compared to a 30% growth forecast for the Chemicals industry in Singapore. Recent Insider Transactions • Nov 14
Executive Director recently bought S$90k worth of stock On the 13th of November, Chee Seng Lee bought around 1m shares on-market at roughly S$0.09 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Announcement • Oct 29
Jiutian Chemical Group Limited has completed a Follow-on Equity Offering in the amount of SGD 10.251 million. Jiutian Chemical Group Limited has completed a Follow-on Equity Offering in the amount of SGD 10.251 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 170,000,000
Price\Range: SGD 0.0603
Discount Per Security: SGD 0.001357
Transaction Features: Subsequent Direct Listing